DK442881A - Prostaglandinholdigt praeparat - Google Patents

Prostaglandinholdigt praeparat

Info

Publication number: DK442881A
Authority: DK; Denmark
Prior art keywords: prostagland; prostaglandin; containing preparation; compositions; dissolved
Prior art date: 1980-10-09

Application number

DK442881A

Other languages

Danish (da)

English (en)

Inventor

H E Gallo-Torres

N H Shah

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-10-09

Filing date

1981-10-06

Publication date

1982-04-10

1981-10-06 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1982-04-10 Publication of DK442881A publication Critical patent/DK442881A/da

Links

CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
239000011786 L-ascorbyl-6-palmitate Substances 0.000 abstract 2
150000003180 prostaglandins Chemical class 0.000 abstract 2
235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 abstract 1
QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 abstract 1
239000002202 Polyethylene glycol Substances 0.000 abstract 1
229960005070 ascorbic acid Drugs 0.000 abstract 1
235000010385 ascorbyl palmitate Nutrition 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
150000004665 fatty acids Chemical class 0.000 abstract 1
239000007903 gelatin capsule Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229920001223 polyethylene glycol Polymers 0.000 abstract 1
229920000136 polysorbate Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK442881A 1980-10-09 1981-10-06 Prostaglandinholdigt praeparat DK442881A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/195,575 US4310543A (en)	1980-10-09	1980-10-09	Prostaglandin compositions

Publications (1)

Publication Number	Publication Date
DK442881A true DK442881A (da)	1982-04-10

Family

ID=22721933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK442881A DK442881A (da)	1980-10-09	1981-10-06	Prostaglandinholdigt praeparat

Country Status (13)

Country	Link
US (1)	US4310543A (cs)
EP (1)	EP0049852B1 (cs)
JP (1)	JPS5793911A (cs)
AT (1)	ATE14981T1 (cs)
AU (1)	AU547175B2 (cs)
CA (1)	CA1176567A (cs)
DE (1)	DE3171928D1 (cs)
DK (1)	DK442881A (cs)
IE (1)	IE51637B1 (cs)
IL (1)	IL63960A (cs)
NZ (1)	NZ198533A (cs)
PH (1)	PH17073A (cs)
ZA (1)	ZA816852B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1216793A (en) *	1982-07-19	1987-01-20	Cheng-Der Yu	Pge-type compositions encapsulated by acid isolated gelatin
US4431833A (en) *	1982-12-27	1984-02-14	American Cyanamid Company	Prostaglandin and hydroxylated fatty acid ester formulations
FR2549371B1 (fr) *	1983-07-20	1985-09-13	Sanofi Sa	Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
JPH0713012B2 (ja) *	1984-02-08	1995-02-15	ア−ルピ− シ−ラ− コ−ポレ−シヨン	アセトアミノフェン・ゼラチンカプセル
DE3438830A1 (de) *	1984-10-23	1986-04-30	Rentschler Arzneimittel	Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
NO882653D0 (no) *	1988-06-15	1988-06-15	Apothekernes Lab	Doseringsform.
DE69105349T2 (de) *	1990-05-22	1995-04-06	Ueno Seiyaku Oyo Kenkyujo Kk	Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
GB2281697A (en) *	1993-09-14	1995-03-15	Euro Celtique Sa	Laxative compositions in capsules
US5962522A (en) *	1997-09-05	1999-10-05	Avmax, Inc.	Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
US6180666B1 (en)	1997-09-05	2001-01-30	Anmax, Inc.	Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
WO2001003695A1 (en) *	1999-07-13	2001-01-18	Avmax, Inc.	Improvement of bioavailability with vitamin c fatty acid esters
KR100649860B1 (ko) *	2000-09-01	2006-11-24	주식회사종근당	알프로스타딜 경점막 및 경피흡수제제
CA2422031C (en) *	2000-09-13	2011-11-15	Santen Pharmaceutical Co., Ltd.	Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
ATE450264T1 (de) *	2003-07-31	2009-12-15	Santen Pharmaceutical Co Ltd	Prostaglandin enthaltendes produkt
EP1660047B1 (en)	2003-08-13	2013-11-27	Biocon Limited	Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
EP1675548A4 (en) *	2003-09-25	2008-08-13	Activbiotics Inc	RIFALAZIL FORMULATIONS
US8541413B2 (en) *	2004-10-01	2013-09-24	Ramscor, Inc.	Sustained release eye drop formulations
US9993558B2 (en)	2004-10-01	2018-06-12	Ramscor, Inc.	Sustained release eye drop formulations
ES2588581T3 (es) *	2004-12-09	2016-11-03	Santen Pharmaceutical Co., Ltd.	Producto que contiene prostaglandina con átomo de flúor en su molécula
DK1829545T3 (da) *	2004-12-24	2012-07-23	Santen Pharmaceutical Co Ltd	Produkter indeholdende prostaglandin-F2alfa-derivat
MX2008012844A (es) *	2006-04-06	2009-01-19	Activbiotics Pharma Llc	Composiciones farmaceuticas y usos de ellas.
WO2009011449A2 (en)	2007-07-19	2009-01-22	R-Tech Ueno, Ltd.	Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound
WO2009052391A1 (en) *	2007-10-19	2009-04-23	Purdue Research Foundation	Solid formulations of crystalline compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2889252A (en) *	1956-05-14	1959-06-02	American Cyanamid Co	Gelatin capsule containing hexylresorcinol and a lower polyalkylene glycol
ZA721937B (en) *	1971-10-22	1972-12-27	Upjohn Co	Pharmaceutical preparations and uses thereof
CA1043259A (en) *	1972-12-08	1978-11-28	Geoffrey F. Thompson	Medicament preparations and vehicles therefor
US3932634A (en) *	1973-06-28	1976-01-13	Pfizer Inc.	High potency vitamin water dispersible formulations
US4052446A (en) *	1973-08-06	1977-10-04	Hoffmann-La Roche Inc.	11,16-substituted prostaglandins
JPS6019734B2 (ja) *	1977-05-12	1985-05-17	三共株式会社	安定なプロスタグランジンｅ類製剤の製法
JPS6046094B2 (ja) *	1977-06-01	1985-10-14	科研製薬株式会社	安定化されたプロスタグランジンｅ類粉末製剤
FI790043A7 (fi) *	1978-01-17	1979-07-18	Sandoz Ag	Prostaglandiner innehaollande terapeutisk sammansaettning

1980
- 1980-10-09 US US06/195,575 patent/US4310543A/en not_active Expired - Lifetime
1981
- 1981-09-09 CA CA000385446A patent/CA1176567A/en not_active Expired
- 1981-09-11 PH PH26191A patent/PH17073A/en unknown
- 1981-09-28 IL IL63960A patent/IL63960A/xx unknown
- 1981-10-02 ZA ZA816852A patent/ZA816852B/xx unknown
- 1981-10-02 NZ NZ198533A patent/NZ198533A/en unknown
- 1981-10-06 AU AU76068/81A patent/AU547175B2/en not_active Ceased
- 1981-10-06 DE DE8181107988T patent/DE3171928D1/de not_active Expired
- 1981-10-06 AT AT81107988T patent/ATE14981T1/de active
- 1981-10-06 EP EP81107988A patent/EP0049852B1/de not_active Expired
- 1981-10-06 DK DK442881A patent/DK442881A/da not_active Application Discontinuation
- 1981-10-08 IE IE2354/81A patent/IE51637B1/en unknown
- 1981-10-08 JP JP56159562A patent/JPS5793911A/ja active Granted

Also Published As

Publication number	Publication date
US4310543A (en)	1982-01-12
AU547175B2 (en)	1985-10-10
JPH032848B2 (cs)	1991-01-17
ZA816852B (en)	1982-09-29
EP0049852A3 (en)	1983-01-26
ATE14981T1 (de)	1985-09-15
NZ198533A (en)	1984-12-14
EP0049852B1 (de)	1985-08-21
IE812354L (en)	1982-04-09
EP0049852A2 (de)	1982-04-21
DE3171928D1 (en)	1985-09-26
JPS5793911A (en)	1982-06-11
PH17073A (en)	1984-05-24
IE51637B1 (en)	1987-01-21
CA1176567A (en)	1984-10-23
IL63960A (en)	1985-05-31
IL63960A0 (en)	1981-12-31
AU7606881A (en)	1982-04-22

Similar Documents

Publication	Publication Date	Title
DE3171928D1 (en)	1985-09-26	Pharmaceutical formulation and its preparation
DE3172223D1 (en)	1985-10-17	Edible, pharmaceutical compositions and processes for making thereof
ATE81588T1 (de)	1992-11-15	Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
DE69321596D1 (de)	1998-11-19	Ester und kombinationen von einem organischen nitrat und einem salicyclat
DK146784D0 (da)	1984-02-29	Farmaceutisk doseringsenhedsform
FR2321892A1 (fr)	1977-03-25	Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
IL56991A0 (en)	1979-07-25	4-halo-3-oxoandrost-4-ene-17 -thiocarboxylic acid esters their preparation and pharmaceutical compositions containing them
DK585889A (da)	1990-05-23	Farmaceutisk praeparat
NO790523L (no)	1979-08-20	Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner
FI845019L (fi)	1985-06-23	Farmaceutiskt preparat foer behandling av reumatiska sjukdomar.
FR2288982A1 (fr)	1976-05-21	Methode et necessaire de dosage par saturation de l'acide folique et de ses composes
BE878020A (fr)	1980-02-01	Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
SE420919B (sv)	1981-11-09	Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
SE8501312D0 (sv)	1985-03-18	Etoposide oral dosage form
FR2449686B1 (fr)	1986-04-25	Nouvel ester de l'acide 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetique et sa preparation, ainsi que medicament le comprenant et sa preparation
JPS5551019A (en)	1980-04-14	Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
AU6724581A (en)	1981-08-20	Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
BE881625A (fr)	1980-05-30	Esters o-alcoxycarbonyl-phenyliques d'un acide anthranilique leur preparation et compositions pharmaceutiques en contenant
FR2607005B1 (fr)	1989-05-05	Compositions pharmaceutiques contenant de l'acide ursodesoxycholique
JPS52130905A (en)	1977-11-02	Medicinal composition
IL56487A (en)	1983-05-15	Quaternary salts of bis isoquinolinoalkyl benzene dicarboxylic acid esters,their preparation and pharmaceutical compositions containing them
DK295079A (da)	1980-01-14	Farmaceutisk komposition indeholdende trimethoprim og n-ethyl-gamma-pyridon-3-carboxylsyrederivater
FI840636A0 (fi)	1984-02-16	Foerfarande foer framstaellning av en fysiologiskt soenderfallande ester av antibakterisk 2 -klormetyl-2 -metylpenam-3 -karboxylsyrasulfon
JPS5251362A (en)	1977-04-25	Preparation of optically active pyrrolidine derivatives
SE8505801L (sv)	1986-06-11	I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa

Legal Events

Date	Code	Title	Description
1990-06-18	AHB	Application shelved due to non-payment